Study of CT071 Injection in High Risk Newly Diagnosed Multiple Myeloma
Status:
RECRUITING
Trial end date:
2027-06-03
Target enrollment:
Participant gender:
Summary
This trial is a single-arm, single-center, open-label clinical trial to evaluate the safety, efficacy, and metabolism kinetics of CT071 in patients with high-risk newly diagnosed multiple myeloma.